FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tatjana Zabelina

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Phenomena

Recurrence

Living Beings

Infants

Co-author Network

Publications

TOP 3
Anthony Oyekunle; Philippe Schafhausen; Thomas Stübig; Christine Wolschke; Tatjana Zabelina; Axel R Zander; Haefaa Alchalby; Francis Ayuk; Ulrike Bacher; Mascha Binder; Maximilian Christopeit; Heinrich Lellek; Ingo Müller; Nicolaus Kröger
Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.
Nicolaus Kröger; Georgia Schilling; Sabine Schwarz; Thomas Stübig; Christine Wolschke; Tatjana Zabelina; Silke Zeschke; Haefaa Alchalby; Djordje Atanackovic; Francis Ayuk; Ulrike Bacher; A Badbaran; Boris Fehse; Timon Hansen; Marion Heinzelmann; Evgeny Klyuchnikov; Axel R Zander
Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myeloma.
Maximilian Christopeit; T Haferlach; Evgeny Klyuchnikov; Nicolaus Kröger; K Miersch; S Ocheni; Philippe Schafhausen; Tatjana Zabelina; A R Zander; Francis Ayuk; M Binder; C Bokemeyer; Anthony Oyekunle
Evaluation of BM cytomorphology after allo-SCT in patients with MDS.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tatjana Zabelina (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Anthony Oyekunle; Philippe Schafhausen; Thomas Stübig; Christine Wolschke; Tatjana Zabelina; Axel R Zander; Haefaa Alchalby; Francis Ayuk; Ulrike Bacher; Mascha Binder; Maximilian Christopeit; Heinrich Lellek; Ingo Müller; Nicolaus Kröger
Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.
Annals of hematology 2013;92(4):487-96.
2013: Nicolaus Kröger; Georgia Schilling; Sabine Schwarz; Thomas Stübig; Christine Wolschke; Tatjana Zabelina; Silke Zeschke; Haefaa Alchalby; Djordje Atanackovic; Francis Ayuk; Ulrike Bacher; A Badbaran; Boris Fehse; Timon Hansen; Marion Heinzelmann; Evgeny Klyuchnikov; Axel R Zander
Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(3):398-404.
2013: Maximilian Christopeit; T Haferlach; Evgeny Klyuchnikov; Nicolaus Kröger; K Miersch; S Ocheni; Philippe Schafhausen; Tatjana Zabelina; A R Zander; Francis Ayuk; M Binder; C Bokemeyer; Anthony Oyekunle
Evaluation of BM cytomorphology after allo-SCT in patients with MDS.
Bone marrow transplantation 2013;48(3):465-6.
2013: Nicolaus Kröger; M Kropff; K-H Pflüger; Georgia Schilling; T Stübig; Christine Wolschke; Tatjana Zabelina; Djordje Atanackovic; Francis Ayuk; Anthony Oyekunle; A Badbaran; A Burchert; T Hansen; Y Hildebrandt; Evgeny Klyuchnikov; Axel R Zander
Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients.
Bone marrow transplantation 2013;48(3):403-7.
2013: Nicolaus Kröger; V Leblond; N Milpied; Mohamad Mohty; M Robin; N Schaap; Anja van Biezen; L Volin; Tatjana Zabelina; H Alchalby; J Berger; D Blaise; Theo de Witte; L de Wreede; J Finke
Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings.
Leukemia 2013;27(3):604-9.
2012: Haefaa Alchalby; Francis Ayuk; Ulrike Bacher; Wolfgang Bethge; Martin Bornhäuser; Guntram Büsche; Ernst Holler; Guido Kobbe; Hans Michael Kvasnicka; Rainer Schwerdtfeger; Dinah-Rohina Yunus; Tatjana Zabelina; Axel R Zander; Nicolaus Kröger
Risk models predicting survival after reduced-intensity transplantation for myelofibrosis.
British journal of haematology 2012;157(1):75-85.
2011: Nicolaus Kröger; T Stübig; Tatjana Zabelina; A R Zander; Y Hilde-brandt; Evgeny Klyuchnikov; H Alchalby; Djordje Atanackovic; Francis Ayuk; U Bacher; J Berger; T Binder; H Duske; Thomas Eiermann
Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma.
Leukemia 2011;25(10):1657-61.
2011: Nicolaus Kröger; Tatjana Zabelina; Anja van Biezen; Ronald Brand; Dietger Niederwieser; Rodrigo Martino; Zi Yi Lim; Francesco Onida; Christoph Schmid; Laurent Garderet; Marie Robin; Michael van Gelder; Reinhard Marks; Argiris Symeonidis; Guido Kobbe; Theo de Witte
Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis.
Haematologica 2011;96(2):291-7.
2011: S Ocheni; Anthony Oyekunle; Nicolaus Kröger; Francis Ayuk; Evgeny Klyuchnikov; Soenke Arps; Karsten Held; Tatjana Zabelina; Raissa Adjallé; Christine Wolschke; Axel Rolf Zander; Anthony Oyekunle
Second allogeneic stem cell transplantation in a patient with hypoplastic myelodysplastic syndrome following a primary diagnosis of aplastic anaemia.
Acta haematologica 2011;125(3):175-8.
2011: Evgeny Klyuchnikov; Ulrike Bacher; Nicolaus Kröger; Ilya Kazantsev; Tatjana Zabelina; Francis Ayuk; Axel Rolf Zander
The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma Patients.
Advances in hematology 2011;2011():974658.
2011: Martin Schmidt-Hieber; Julie Schwender; Werner J Heinz; Tatjana Zabelina; Jörn S Kühl; Sabine Mousset; Silke Schüttrumpf; Christian Junghanss; Gerda Silling; Nadezda Basara; Stefan Neuburger; Eckhard Thiel; Igor Wolfgang Blau
Viral encephalitis after allogeneic stem cell transplantation: a rare complication with distinct characteristics of different causative agents.
Haematologica 2011;96(1):142-9.
2010: Bettina Wiedemann; Evgeny Klyuchnikov; Nicolaus Kröger; Tatjana Zabelina; Tanja Stahl; Silke Zeschke; A Badbaran; Francis Ayuk; Haefaa Alchalby; Christine Wolschke; Carsten Bokemeyer; Boris Fehse; Axel R Zander; Ulrike Bacher
Chimerism studies with quantitative real-time PCR in stem cell recipients with acute myeloid leukemia.
Experimental hematology 2010;38(12):1261-71.
2010: Haefaa Alchalby; A Badbaran; Tatjana Zabelina; Guido Kobbe; Joachim Hahn; Daniel Wolff; Martin Bornhäuser; Christian Thiede; Herrad Baurmann; Wolfgang Bethge; York Hildebrandt; Ulrike Bacher; Boris Fehse; Axel R Zander; Nicolaus Kröger
Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis.
Blood 2010;116(18):3572-81.
2010: Tanja Stahl; A Badbaran; Nicolaus Kröger; Evgeny Klyuchnikov; Tatjana Zabelina; Silke Zeschke; Philippe Schafhausen; Waltraud Schultz; Svetlana Asenova; Anna Smirnova; Christine Wolschke; Francis Ayuk; Axel R Zander; Boris Fehse; Ulrike Bacher
Minimal residual disease diagnostics in patients with acute myeloid leukemia in the post-transplant period: comparison of peripheral blood and bone marrow analysis.
Leukemia & lymphoma 2010;51(10):1837-43.
2010: Irene Cavattoni; Francis Ayuk; Axel R Zander; Tatjana Zabelina; Adelbert Bacher; Erdogan Cayroglu; Volker Knospe; Till Illies; Martin Aepfelbacher; Gisbert Richard; Nicolaus Kröger; Ulrike Bacher
Diagnosis of Toxoplasma gondii infection after allogeneic stem cell transplant can be difficult and requires intensive scrutiny.
Leukemia & lymphoma 2010;51(8):1530-5.
2009: Nicolaus Kröger; Ernst Holler; Guido Kobbe; Martin Bornhäuser; Rainer Schwerdtfeger; Herrad Baurmann; Arnon Nagler; Wolfgang Bethge; Matthias Stelljes; Lutz Uharek; Hannes Wandt; Andreas Burchert; Paolo Corradini; Jörg Schubert; Martin Kaufmann; Peter Dreger; Gerald G Wulf; Hermann Einsele; Tatjana Zabelina; Hans Michael Kvasnicka; Jürgen Thiele; Ronald Brand; Axel R Zander; Dietger Niederwieser; Theo M de Witte
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Blood 2009;114(26):5264-70.
2009: Ulrike Bacher; Evgeny Klyuchnikov; Tatjana Zabelina; Hellmut Ottinger; Dietrich W Beelen; Hubert Schrezenmeier; Gerhard Ehninger; Carlheinz Müller; Jürgen Berger; Meinolf Suttorp; Hans-Jochem Kolb; Nicolaus Kröger; Axel R Zander
The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia--a report from the German Registry covering the period from 1998 to 2004.
Annals of hematology 2009;88(12):1237-47.
2009: Nicolaus Kröger; A Badbaran; Michael V Lioznov; Sabine Schwarz; Silke Zeschke; York Hildebrand; Francis Ayuk; Djordje Atanackovic; Georgia Schilling; Tatjana Zabelina; Ulrike Bacher; Evgeny Klyuchnikov; Avichai Shimoni; Arnon Nagler; Paolo Corradini; Boris Fehse; Axel Zander
Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma.
Experimental hematology 2009;37(7):791-8.
2009: Sunday Ocheni; Gabriela B Iwanski; Philippe Schafhausen; Axel R Zander; Francis Ayuk; Evgeny Klyuchnikov; Tatjana Zabelina; Walter Fiedler; Susanne Schnittger; Andreas Hochhaus; Tim H Brümmendorf; Nicolaus Kröger; Ulrike Bacher
Characterisation of extramedullary relapse in patients with chronic myeloid leukemia in advanced disease after allogeneic stem cell transplantation.
Leukemia & lymphoma 2009;50(4):551-8.
2009: Nicolaus Kröger; Tatjana Zabelina; Thomas Binder; Francis Ayuk; Ulrike Bacher; Gitta Amtsfeld; Heinrich Lellek; J Schrum; Rudolf Erttmann; Thomas Eiermann; Axel Zander
HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(4):454-62.
2009: S Ocheni; Tatjana Zabelina; Ulrike Bacher; Francis Ayuk; Axel Zander; Nicolaus Kröger
Pegfilgrastim compared to lenograstim after allogeneic peripheral blood stem-cell transplantation from unrelated donors.
Leukemia & lymphoma 2009;50(4):612-8.
2009: Maite Hartwig; Sunday Ocheni; Svetlana Asenova; Bettina Wiedemann; Tatjana Zabelina; Francis Ayuk; Hartmut Kabisch; Rudolf Erttmann; Nicolaus Kröger; Axel Rolf Zander; Ulrike Bacher
Second allogeneic stem cell transplantation in myeloid malignancies.
Acta haematologica 2009;122(4):185-92.
2009: Evgeny Klyuchnikov; Philippe Schafhausen; Nicolaus Kröger; Tim H Brummendorf; Okay Osanmaz; Svetlana Asenova; Tatjana Zabelina; Sunday Ocheni; Francis Ayuk; Axel R Zander; Ulrike Bacher
Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia.
Acta haematologica 2009;122(1):6-10.
2008: Francis Ayuk; Jose A Perez-Simon; Avichai Shimoni; Anna Sureda; Tatjana Zabelina; Rainer Schwerdtfeger; Rodrigo Martino; Herbert G Sayer; Adrián Alegre; Juan José Lahuerta; Djordje Atanackovic; Christine Wolschke; Arnon Nagler; Axel R Zander; Jesús F San Miguel; Nicolaus Kröger
Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.
Haematologica 2008;93(9):1343-50.
2008: Francis Ayuk; Galina Diyachenko; Tatjana Zabelina; Christine Wolschke; Boris Fehse; Ulrike Bacher; Rudolf Erttmann; Nicolaus Kröger; Axel R Zander
Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(8):913-9.
2008: Francis Ayuk; Galina Diyachenko; Tatjana Zabelina; Jens Panse; Christine Wolschke; Thomas Eiermann; Thomas Binder; Boris Fehse; Rudolf Erttmann; Hartmut Kabisch; Ulrike Bacher; Nicolaus Kröger; Axel R Zander
Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
Experimental hematology 2008;36(8):1047-54.
2008: Georgia Schilling; T Hansen; Avichai Shimoni; Tatjana Zabelina; J-A Pérez-Simón; J-A Simon-Perez; N C Gutierrez; W Bethge; P Liebisch; Rainer Schwerdtfeger; Martin Bornhäuser; S Otterstetter; E M M Penas; Judith Dierlamm; Francis Ayuk; Djordje Atanackovic; Ulrike Bacher; Carsten Bokemeyer; A Zander; J San Miguel; J S Miguel; Arnon Nagler; Nicolaus Kröger
Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma.
Leukemia 2008;22(6):1250-5.
2007: Nicolaus Kröger; Anita Badbaran; Ernst Holler; Joachim Hahn; Guido Kobbe; Martin Bornhäuser; Andreas Reiter; Tatjana Zabelina; Axel R Zander; Boris Fehse
Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis.
Blood 2007;109(3):1316-21.
2006: Nicolaus Kröger; Thomas Binder; Tatjana Zabelina; Christine Wolschke; Heike Schieder; Helmut Renges; Francis Ayuk; Joachim Dahlke; Thomas Eiermann; Axel Zander
Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation.
Transplantation 2006;82(8):1024-30.
2006: Nicolaus Kröger; Tatjana Zabelina; Francis Ayuk; Djordje Atanackovic; Heike Schieder; Helmut Renges; Axel Zander
Bortezomib after dose-reduced allogeneic stem cell transplantation for multiple myeloma to enhance or maintain remission status.
Experimental hematology 2006;34(6):770-5.
2006: Nicolaus Kröger; Maria Zagrivnaja; Sabine Schwartz; Anita Badbaran; Tatjana Zabelina; Michael V Lioznov; Francis Ayuk; Axel Zander; Boris Fehse
Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma.
Experimental hematology 2006;34(5):688-94.
2006: Nicolaus Kröger; Avichai Shimoni; Tatjana Zabelina; Heike Schieder; Jens Panse; Francis Ayuk; Christine Wolschke; Helmut Renges; Joachim Dahlke; Djordje Atanackovic; Arnon Nagler; Axel Zander
Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS).
Bone marrow transplantation 2006;37(4):339-44.
2006: Anthony Oyekunle; U Koehl; Heike Schieder; Francis Ayuk; Helmut Renges; Natalja Fehse; Tatjana Zabelina; B Fehse; T Klingebiel; Andreas Sputtek; Ar Zander; N Kröger
CD34(+)-selected stem cell boost for delayed or insufficient engraftment after allogeneic stem cell transplantation.
Cytotherapy 2006;8(4):375-80.
2006: Joachim Dahlke; Nicolaus Kröger; Tatjana Zabelina; Francis Ayuk; Natalja Fehse; Christine Wolschke; Olga Waschke; Heike Schieder; Helmut Renges; William H Krüger; A Kruell; Axel Hinke; Rudolf Erttmann; Hartmut Kabisch; Axel R Zander
Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation.
Bone marrow transplantation 2006;37(2):155-63.
2006: Anthony Oyekunle; Nicolaus Kröger; Tatjana Zabelina; Francis Ayuk; Heike Schieder; Helmut Renges; Natalja Fehse; Olga Waschke; Boris Fehse; Hartmut Kabisch; Axel R Zander
Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up.
Bone marrow transplantation 2006;37(1):45-50.
2005: Nicolaus Kröger; Bronwen Shaw; Simona Iacobelli; Tatjana Zabelina; Karl S Peggs; Avichai Shimoni; Arnon Nagler; Thomas Binder; Thomas Eiermann; Alejandro Madrigal; Rainer Schwerdtfeger; Michael Kiehl; Herbert G Sayer; Jörg Beyer; Martin Bornhäuser; Francis Ayuk; Axel R Zander; David I Marks
Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma.
British journal of haematology 2005;129(5):631-43.
2005: Johannes Schetelig; Astrid Breitschaft; Nicolaus Kröger; Tatjana Zabelina; Wolfram Ebell; Martin Bornhäuser; Astrid Haack; Gerhard Ehninger; Abdulgabar Salama; Wolfgang Siegert
After major ABO-mismatched allogeneic hematopoietic progenitor cell transplantation, erythroid engraftment occurs later in patients with donor blood group A than donor blood group B.
Transfusion 2005;45(5):779-87.
2005: Nicolaus Kröger; Tatjana Zabelina; Heike Schieder; Jens Panse; Francis Ayuk; Norbert Stute; Natalja Fehse; Olga Waschke; Boris Fehse; Hans Michael Kvasnicka; Jürgen Thiele; Axel Zander
Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis.
British journal of haematology 2005;128(5):690-7.
2005: Avichai Shimoni; N Kröger; Tatjana Zabelina; Francis Ayuk; Izhar Hardan; Moshe Yeshurun; Noga Shem-Tov; Abraham Avigdor; Isaac Ben-Bassat; A R Zander; Arnon Nagler
Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning.
Leukemia 2005;19(1):7-12.
2004: Boris Fehse; Francis Ayuk; Nicolaus Kröger; Lubin Fang; Klaus Kühlcke; Marion Heinzelmann; Tatjana Zabelina; Axel A Fauser; Axel R Zander
Evidence for increased risk of secondary graft failure after in vivo depletion of suicide gene-modified T lymphocytes transplanted in conjunction with CD34+-enriched blood stem cells.
Blood 2004;104(10):3408-9.
2004: Nicolaus Kröger; Avichai Shimoni; Maria Zagrivnaja; Francis Ayuk; Michael V Lioznov; Heike Schieder; Helmut Renges; Boris Fehse; Tatjana Zabelina; Arnon Nagler; Axel R Zander
Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma.
Blood 2004;104(10):3361-3.
2004: Nicolaus Kröger; Jose A Perez-Simon; Han Myint; Hans Klingemann; Avichai Shimoni; Arnon Nagler; Rodrigo Martino; Adrian Alegre; Jose F Tomas; Rainer Schwerdtfeger; Michael Kiehl; Axel A Fauser; Herbert G Sayer; Angel Leon; Jörg Beyer; Tatjana Zabelina; Francis Ayuk; Jesús F San Miguel; Ronald Brand; Axel R Zander
Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(10):698-708.
2004: Nicolaus Kröger; Georgia Schilling; Hermann Einsele; Peter Liebisch; Avichai Shimoni; Arnon Nagler; Jose A Perez-Simon; Jesús F San Miguel; Michael Kiehl; Axel A Fauser; Rainer Schwerdtfeger; Hannes Wandt; Herbert G Sayer; Han Myint; Hans Klingemann; Tatjana Zabelina; Judith Dierlamm; Axel Hinke; Axel R Zander
Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation.
Blood 2004;103(11):4056-61.
2004: Johannes Schetelig; Martin Bornhäuser; Michael Kiehl; Rainer Schwerdtfeger; Nicolaus Kröger; Volker Runde; Tatjana Zabelina; Thomas K Held; Christian Thiede; Axel A Fauser; D Beelen; Axel Zander; Gerhard Ehninger; Wolfgang Siegert
Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysis.
Bone marrow transplantation 2004;33(5):483-90.
2004: Francis Ayuk; Avichai Shimoni; A Nagler; Rainer Schwerdtfeger; M Kiehl; Herbert G Sayer; Tatjana Zabelina; A R Zander; N Kröger
Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma.
Leukemia 2004;18(3):659-62.
2003: Axel R Zander; Nicolaus Kröger; Michael Schleuning; J Finke; Tatjana Zabelina; Dietrich W Beelen; Rainer Schwerdtfeger; H Baurmann; Martin Bornhäuser; Gerhard Ehninger; Axel A Fauser; Michael Kiehl; Rudolf Trenschel; Hellmut D Ottinger; H Bertz; J Berger; Hans-Jochem Kolb; Ulrich W Schaefer
ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML).
Bone marrow transplantation 2003;32(4):355-61.
2003: Nicolaus Kröger; Hermann Einsele; Daniel Wolff; Jochen Casper; Mathias Freund; Günter Derigs; Hannes Wandt; K Schäfer-Eckart; Georg Wittkowsky; Norbert Schmitz; William H Krüger; Tatjana Zabelina; Helmut Renges; Francis Ayuk; Andreas Krüll; Axel Zander
Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM).
Bone marrow transplantation 2003;31(11):973-9.
2003: M Weber; Nicolaus Kröger; Florian Langer; A Hansen; Tatjana Zabelina; Barbara Eifrig; Dieter K Hossfeld; Axel R Zander
Non-overt disseminated intravascular coagulation in patients during treatment with antithymocyte globulin for unrelated allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2003;31(9):817-22.
2003: Natalja Fehse; Boris Fehse; Nicolaus Kröger; Tatjana Zabelina; Petra Freiberger; William H Krüger; Hartmut Kabisch; Rudolf Erttmann; Axel R Zander
Influence of anti-thymocyte globulin as part of the conditioning regimen on immune reconstitution following matched related bone marrow transplantation.
Journal of hematotherapy & stem cell research 2003;12(2):237-42.
2002: Jörg Hessling; Nicolaus Kröger; Mathias Werner; Tatjana Zabelina; Arne Hansen; Uwe Kordes; Francis Ayuk; Helmut Renges; Jens Panse; Rudolf Erttmann; Axel R Zander
Dose-reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia.
British journal of haematology 2002;119(3):769-72.
2002: Nicolaus Kröger; Herbert G Sayer; Rainer Schwerdtfeger; Michael Kiehl; Arnon Nagler; Helmut Renges; Tatjana Zabelina; Boris Fehse; Francis Ayuk; Georg Wittkowsky; Norbert Schmitz; Axel R Zander
Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality.
Blood 2002;100(12):3919-24.
2002: Nicolaus Kröger; Tatjana Zabelina; Helmut Renges; William H Krüger; Uwe Kordes; Johannes Rischewski; J Schrum; Martin Horstmann; Francis Ayuk; Rudolf Erttmann; Hartmut Kabisch; Axel R Zander
Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.
Annals of hematology 2002;81(11):627-31.
2002: Nicolaus Kröger; Rainer Schwerdtfeger; Michael Kiehl; Herbert G Sayer; Helmut Renges; Tatjana Zabelina; Boris Fehse; Florian Tögel; Georg Wittkowsky; Rolf Kuse; Axel R Zander
Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma.
Blood 2002;100(3):755-60.
2002: F Graf Finckenstein; Tatjana Zabelina; Matthias Dürken; Joachim Dahlke; Nicolaus Kröger; William H Krüger; Gritta E Janka-Schaub; Rudolf Erttmann; Axel R Zander; Hartmut Kabisch
[Unrelated donor stem cell transplantation in children: low toxicity using a GvHD-prophylaxis regimen with CSA, MTX, metronidazole,iv-immunoglobulin and ATG].
Klinische Pädiatrie 2002;214(4):206-11.
2002: Nicolaus Kröger; Tatjana Zabelina; Philippe Guardiola; Volker Runde; Jorge Sierra; Anja van Biezen; Dietger Niederwieser; Axel R Zander; Theo de Witte
Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia. A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
British journal of haematology 2002;118(1):67-73.
2002: Nicolaus Kröger; Tatjana Zabelina; William H Krüger; Helmut Renges; Norbert Stute; Johannes Rischewski; Stefan Sonnenberg; Francis Ayuk; Florian Tögel; UM Schade; Henning C Fiegel; Rudolf Erttmann; C Löliger; Axel R Zander
In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors.
Bone marrow transplantation 2002;29(8):683-9.
2002: Johannes Schetelig; Nicolaus Kröger; Thomas K Held; Christian Thiede; Andreas Krusch; Tatjana Zabelina; Marc Dubiel; Oliver Rick; Martin Bornhäuser; Gerhard Ehninger; Axel R Zander; Wolfgang Siegert
Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease.
Haematologica 2002;87(3):299-305.
2001: Nicolaus Kröger; Johannes Schetelig; Tatjana Zabelina; William H Krüger; Helmut Renges; Norbert Stute; J Schrum; Hartmut Kabisch; Wolfgang Siegert; Axel R Zander
A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
Bone marrow transplantation 2001;28(7):643-7.
2001: Boris Fehse; A Chukhlovin; Klaus Kühlcke; O Marinetz; O Vorwig; Helmut Renges; William H Krüger; Tatjana Zabelina; O Dudina; F G Finckenstein; Nicolaus Kröger; Hartmut Kabisch; A Hochhaus; Axel R Zander
Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation.
Journal of hematotherapy & stem cell research 2001;10(3):419-25.
2001: Nicolaus Kröger; Tatjana Zabelina; William H Krüger; Helmut Renges; Norbert Stute; J Schrum; Hartmut Kabisch; Philippe Schafhausen; N Jaburg; C Löliger; P Schäfer; Axel Hinke; Axel R Zander
Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin.
British journal of haematology 2001;113(4):1060-71.
2001: Nicolaus Kröger; Tatjana Zabelina; William H Krüger; Helmut Renges; Norbert Stute; Matthias Dürken; F Graf von Finkenstein; Rudolf Erttmann; Hartmut Kabisch; Philippe Schafhausen; N Jaburg; C Löliger; Axel R Zander
Anti-thymocyte-globulin as part of the preparative regimen prevents graft failure and severe graft versus host disease (GvHD) in allogeneic stem cell transplantation from unrelated donors.
Annals of hematology 2001;80(4):209-15.
2001: Nicolaus Kröger; Tatjana Zabelina; William H Krüger; Helmut Renges; Norbert Stute; Hartmut Kabisch; N Jaburg; C Löliger; Andreas Krüll; Axel R Zander
Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients.
Bone marrow transplantation 2001;27(4):349-54.
2001: Nicolaus Kröger; William H Krüger; Helmut Renges; Tatjana Zabelina; Norbert Stute; R Jung; Georg Wittkowsky; Rolf Kuse; Axel Zander
Donor lymphocyte infusion enhances remission status in patients with persistent disease after allografting for multiple myeloma.
British journal of haematology 2001;112(2):421-3.
2000: Nicolaus Kröger; Tatjana Zabelina; Stefan Sonnenberg; William H Krüger; Helmut Renges; Norbert Stute; F Finkenstein; U Mayer; K Holstein; Walter Fiedler; H Colberg; Ruth Sonnen; Rolf Kuse; Dietrich Braumann; Bernd Metzner; F del Valle; Rudolf Erttmann; Hartmut Kabisch; Axel R Zander
Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
Bone marrow transplantation 2000;26(7):711-6.
1999: Axel R Zander; Tatjana Zabelina; Nicolaus Kröger; Helmut Renges; William H Krüger; C Löliger; Matthias Dürken; Marcus Stockschläder; Maike de Wit; G Wacker-Backhaus; Stefan S Bielack; N Jaburg; Bettina Rüssmann; Rudolf Erttmann; Hartmut Kabisch
Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow.
Bone marrow transplantation 1999;23(9):889-93.